top of page
VALUE-ADD INVESTOR IN TRANSFORMATIONAL MEDICAL TECHNOLOGIES
The BioStar Capital Advantage
Our unique strategy has consistently produced life-changing outcomes for patients and rewarding returns for investors.
Business Acumen Meets
Clinical Expertise
Representing a unique collaboration of renowned healthcare clinicians and executives, medical thought leaders, and financial professionals.
Portfolio Milestone: AVS Acquired by Stryker
Amplitude Vascular Systems (AVS), developer of the Pulse IVL platform and a BioStar Capital portfolio company, has been acquired by Stryker.
.png)
Innovations with
an Impact
We have been at the forefront of transformational medical technology and investment opportunities for over two decades.
bottom of page